03933

The United Laboratories Internat…

13.04

0.26+2.03%

Closed16:08 05/13 HKT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE12.900/12.780

TODAY RANGE12.800-13.140

VOL7.55M

MARKET CAP23.69B

52 WEEK RANGE7.840-16.960

AVG VOL (3M)13.99M

% TURNOVER0.42%

TURNOVER98.03M

P/E (TTM)8.250

% RANGE2.66%

EPS(TTM)1.581

P/E(FORWARD)6.436

P/B1.525

BVPS8.551

DIVIDEND0.472

P/S1.649

BETA--

DIV YIELD3.62%

FREE FLOAT MKT CAP23.69B

SHARES OUTSTANDING1.82B

NEXT EARNINGS08/27-09/01

FREE FLOAT1.82B

LOT SIZE2000

EX-DIV DATE07/08/2025

News

Press Releases

Financial Reports

Profile

Simply Wall St·05/01 23:37
United Laboratories International Holdings Full Year 2024 Earnings: Misses Expectations
Simply Wall St·04/23 22:53
United Laboratories International Holdings (HKG:3933) Has A Pretty Healthy Balance Sheet
Simply Wall St·03/28 00:13
Earnings Miss: The United Laboratories International Holdings Limited Missed EPS By 9.8% And Analysts Are Revising Their Forecasts
Simply Wall St·03/25 23:02
United Laboratories International Holdings Full Year 2024 Earnings: Misses Expectations
Simply Wall St·03/24 23:01
What The United Laboratories International Holdings Limited's (HKG:3933) 26% Share Price Gain Is Not Telling You
Reuters·03/24 10:46
UPDATE 1-Novo licenses China-based biotech's weight-loss drug candidate for up to $2 billion
Reuters·03/24 10:19
Novo Nordisk secures license to weight-loss drug candidate from China's United Labs
Simply Wall St·03/21 01:27
The United Laboratories International Holdings Limited's (HKG:3933) largest shareholders are private companies who were rewarded as market cap surged HK$2.7b last week
Reuters·03/03 14:17
UNITED LABORATORIES INTERNATIONAL - UBT251 INJECTION APPROVED FOR PHASE II CLINICAL TRIAL BY U.S. FOOD AND DRUG ADMINISTRATION
Simply Wall St·02/27 22:56
Is The United Laboratories International Holdings Limited's (HKG:3933) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Simply Wall St·02/05 23:20
Benign Growth For The United Laboratories International Holdings Limited (HKG:3933) Underpins Its Share Price
Simply Wall St·01/10 01:16
Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Simply Wall St·12/19/2024 23:36
Private companies are The United Laboratories International Holdings Limited's (HKG:3933) biggest owners and were hit after market cap dropped HK$1.2b
Simply Wall St·11/28/2024 22:57
Are Robust Financials Driving The Recent Rally In The United Laboratories International Holdings Limited's (HKG:3933) Stock?
Simply Wall St·11/11/2024 00:12
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely

Same Industry

Name/Symbol

Change%

Price

The United Laboratories International Holdings

03933

+2.03%

13.040

Amgen

04332

Wuxi Apptec

02359

-0.64%

62.400

Asymchem Laboratories (Tianjin)

06821

+1.40%

54.450

China Conch Venture Holdings

00586

-1.53%

7.700

Sinopharm Group

01099

-1.07%

18.420

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

-0.93%

17.020

Livzon Pharmaceutical Group

01513

-0.19%

26.150

Shanghai Pharmaceuticals Holding

02607

-1.78%

11.020

Shanghai Fosun Pharmaceutical (Group)

02196

-1.14%

13.920

China Medical System Holdings

00867

-0.97%

8.160

SciClone Pharmaceuticals (Holdings)

06600

0.00%

18.720

China Isotope & Radiation

01763

-0.34%

11.620

Wuxi Biologics (Cayman)

02269

-0.43%

23.150

China Shineway Pharmaceutical Group

02877

-1.11%

7.140

Consun Pharmaceutical Group

01681

+0.21%

9.440

3SBio

01530

+2.50%

11.500

Shandong Xinhua Pharmaceutical

00719

-0.35%

5.690

Beijing Tong Ren Tang Chinese Medicine

03613

-1.28%

8.480

China Resources Pharmaceutical Group

03320

-1.20%

4.950

CSPC Pharmaceutical Group

01093

+0.55%

5.530

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.